Andrew Gottesdiener insider trades

Open-market stock purchases and sales by Andrew Gottesdiener, Director at Apogee Therapeutics, Inc, from SEC Form 4 filings since Jul 13, 2023.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • APGE Apogee Therapeutics, Inc: other filings, last Jun 17, 2025

Get free alerts when Andrew Gottesdiener files a new trade →